Article(id=1325223584355983456, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.06.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1766851200000, receivedDateStr=2025-12-28, revisedDate=1774368000000, revisedDateStr=2026-03-25, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887523973, onlineDateStr=2026-11-05, pubDate=1781020800000, pubDateStr=2026-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887523973, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887523973, creator=13701087609, updateTime=1793887523973, updator=13701087609, issue=Issue{id=1325223559286620353, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='6', pageStart='589', pageEnd='708', issueExtLink='null', onlineDate='null', pubDate='1781020800000', pubDateStr='2026-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887517997, creator='13701087609', updateTime=1793934768161, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421740901413504, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421740901413505, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=589, endPage=594, ext={EN=ArticleExt(id=1325223584620224609, articleId=1325223584355983456, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress in the application of anti-CD20 monoclonal antibodies in refractory nephrotic syndrome, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Refractory nephrotic syndrome(RNS) is a subtype of primary NS with high treatment difficulty, mainly including steroid-resistant NS and steroid-dependent/frequently relapsing NS. Traditional immunosuppressants have limited efficacy and insufficient safety, which can hardly meet current clinical demands. Anti-CD20 monoclonal antibody(anti-CD20McAb) has shown outstanding performance in the treatment of RNS due to its targeting specificity. This review focuses on anti-CD20McAb drugs, including rituximab, ofatumumab, and obinutuzumab, analyzes their related mechanisms of action, as well as the clinical efficacy and differences among common pathological types of RNS, to provide a reference for clinical practice.

, authors=Honglei WU1, Danying YAN1, Niansong WANG2, *, Junhui LI1, *, authorsList=Honglei WU, Danying YAN, Niansong WANG, Junhui LI, authorCompany=null, correspAuthors=Niansong WANG, Junhui LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223584938991714, articleId=1325223584355983456, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=抗CD20单克隆抗体在难治性肾病综合征中的应用进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

难治性肾病综合征(refractory nephrotic syndrome,RNS)是原发性肾病综合征中治疗难度较高的亚型,主要包括激素抵抗型和激素依赖/频复发型肾病综合征。传统免疫抑制剂疗效局限且安全性不足,难以满足目前临床需求。抗CD20单克隆抗体凭借靶向性,在RNS治疗中表现优异。现围绕以利妥昔单抗、奥法妥木单抗、奥妥珠单抗为代表的抗CD20单克隆抗体药物展开综述,分析相关作用机制,以及在RNS常见病理类型中的临床疗效与作用差异,为临床提供参考。

, authors=吴宏磊1, 严丹莹1, 汪年松2, *, 李军辉1, *, authorsList=吴宏磊, 严丹莹, 汪年松, 李军辉, authorCompany=null, correspAuthors=汪年松, 李军辉, authorNote=

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

, correspAuthorsNote=
汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤发病机制和防治
李军辉,副教授,主任医师,研究方向:继发性肾病发病机制和防治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=8uLjrTxy3X+7mBluQ5Nicw==, magXml=A0KaPNr0FTiekmiitI3lzw==, pdfUrl=null, pdf=1QolHjgZ1WDaWuPsvy11lQ==, pdfFileSize=973969, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=pEztgXCIeLOzAmVIqL9zMA==, mapNumber=null, fund=null)}, authors=[Author(id=1325223585475862634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223587161972844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223585475862634, language=EN, stringName=Honglei WU, firstName=Honglei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589087158381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223585475862634, language=CN, stringName=吴宏磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio={"content":"

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

"}, bioImg=null, bioContent=

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])]), Author(id=1325223589233959023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223589334622321, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589233959023, language=EN, stringName=Danying YAN, firstName=Danying, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589460451442, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589233959023, language=CN, stringName=严丹莹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio={"content":"

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

"}, bioImg=null, bioContent=

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])]), Author(id=1325223589577891956, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223589674360950, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589577891956, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589762441335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589577891956, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585362616422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=2., ext=[AuthorCompanyExt(id=1325223585375199335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223585387782248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])]), Author(id=1325223589858910329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223589963767931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589858910329, language=EN, stringName=Junhui LI, firstName=Junhui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223591712792700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589858910329, language=CN, stringName=李军辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])])], keywords=[Keyword(id=1325223591863787645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=EN, orderNo=1, keyword=anti-CD20 monoclonal antibody), Keyword(id=1325223591977033854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=EN, orderNo=2, keyword=refractory nephrotic syndrome), Keyword(id=1325223592073502847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=EN, orderNo=3, keyword=immunotherapy), Keyword(id=1325223592153194624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=EN, orderNo=4, keyword=B cell depletion), Keyword(id=1325223592245469313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=CN, orderNo=1, keyword=抗CD20单克隆抗体), Keyword(id=1325223592392269954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=CN, orderNo=2, keyword=难治性肾病综合征), Keyword(id=1325223592530681987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=CN, orderNo=3, keyword=免疫治疗), Keyword(id=1325223592627150980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, language=CN, orderNo=4, keyword=B细胞耗竭)], refs=[Reference(id=1325223593021415559, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=FLOEGE J, GIBSON KL, VIVARELLI M, et al. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J]. Kidney Int, 2025,107(5S): S241-S289., articleTitle=null, refAbstract=null), Reference(id=1325223596519465097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FLOEGE J, GIBSON KL, VIVARELLI M, et al. Executive summary of the KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J]. Kidney Int, 2025, 107(5): 806-808., articleTitle=null, refAbstract=null), Reference(id=1325223596615934090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ROVIN BH, ADLER SG, BARRATT J, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases[J]. Kidney Int, 2021, 100(4): S1-S276., articleTitle=null, refAbstract=null), Reference(id=1325223596716597387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=FERVENZA FC, APPEL GB, BARBOUR SJ, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy[J]. N Engl J Med, 2019, 381(1): 36-46., articleTitle=null, refAbstract=null), Reference(id=1325223596804677772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=张浩, 蒲正川, 刘丹, 等. 利妥昔单抗联合钙调磷酸酶抑制剂治疗难治性肾病综合征的远期疗效与安全性[J]. 现代生物医学进展, 2025, 25(12): 1948-1954., articleTitle=null, refAbstract=null), Reference(id=1325223596892758157, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=TRAUTMANN A, BOYER O, HODSON E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome[J]. Pediatr Nephrol, 2023, 38(3): 877-919., articleTitle=null, refAbstract=null), Reference(id=1325223597031170190, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=黄瑶, 施克雯, 朱雪婧, 等. 中国单中心 9 310 例肾活检病理诊断疾病谱[J]. 中南大学学报(医学版), 2022, 47(5): 546-554., articleTitle=null, refAbstract=null), Reference(id=1325223597131833487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=陈勇, 王亚倩, 宁小元, 等. 低剂量利妥昔单抗与环磷酰胺分别联合泼尼松治疗难治性肾病综合征患者的临床评价[J]. 中国药物应用与监测, 2025, 22(5): 938-941., articleTitle=null, refAbstract=null), Reference(id=1325223597228302480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=刘纹, 许勇芝. 难治性特发性膜性肾病诊治进展[J]. 海南医学, 2021, 32(4): 511-515., articleTitle=null, refAbstract=null), Reference(id=1325223597312188561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=周雅洁, 吴娅妃. 利妥昔单抗联合环孢素 A 治疗难治性肾病综合征对血清炎症因子肾功能的影响[J]. 中国药物与临床, 2023, 23(5): 297-301., articleTitle=null, refAbstract=null), Reference(id=1325223597412851858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=KUIJPERS TW, BENDE RJ, BAARS PA, et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses[J]. J Clin Invest, 2010, 120(1): 214-222., articleTitle=null, refAbstract=null), Reference(id=1325223597492543635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=PAVLASOVA G, MRAZ M. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy[J]. Haematologica, 2020, 105(6): 1494-1506., articleTitle=null, refAbstract=null), Reference(id=1325223597568041108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BOROSS P, LEUSEN JH. Mechanisms of action of CD20 antibodies[J]. Am J Cancer Res, 2012, 2(6): 676-690., articleTitle=null, refAbstract=null), Reference(id=1325223597643538581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SMITH MR. Rituximab(monoclonal anti-CD20 antibody):mechanisms of action and resistance[J]. Oncogene, 2003,22(47): 7359-7368., articleTitle=null, refAbstract=null), Reference(id=1325223597727424662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=BECK LH, BONEGIO RG, LAMBEAU G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1):11-21., articleTitle=null, refAbstract=null), Reference(id=1325223597823893655, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=TOMAS NM, BECK LH, MEYER-SCHWESINGER C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24):2277-2287., articleTitle=null, refAbstract=null), Reference(id=1325223597916168344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=DOTSCH J, MULLER-WIEFEL DE, KEMPER MJ. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?[J]. Pediatr Nephrol, 2008, 23(1): 3-7., articleTitle=null, refAbstract=null), Reference(id=1325223598012637337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=金众鑫, 乔玉峰. 利妥昔单抗在难治性肾病综合征中的应用现状[J]. 中华肾病研究电子杂志, 2018, 7(5): 234-237., articleTitle=null, refAbstract=null), Reference(id=1325223598088134810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=于晓艳, 孙珊珊, 李双宇, 等. 对比利妥昔单抗、环磷酰胺及他克莫司治疗肾病综合征的临床研究[J]. 中外医疗, 2023, 42(15): 134-137., articleTitle=null, refAbstract=null), Reference(id=1325223598163632283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=徐丽梨, 胡晓帆, 李灏, 等. 利妥昔单抗治疗 PLA2R 阴性的原发性膜性肾病患者疗效预测相关指标的研究[J]. 诊断学理论与实践, 2025, 24(3): 279-285., articleTitle=null, refAbstract=null), Reference(id=1325223598255906972, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=TRACHTMAN H, DESMOND H, WILLIAMS AL, et al. Rationale and design of the nephrotic syndrome study network(NEPTUNE) match in glomerular diseases:designing the right trial for the right patient, today[J]. Kidney Int, 2024, 105(2): 218-230., articleTitle=null, refAbstract=null), Reference(id=1325223598356570269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=向金波, 沈官国, 李政, 等. 抗 CD20 单抗在儿童难治性肾病综合征中的临床应用进展[J]. 中国药房, 2025, 36(16):2078-2084., articleTitle=null, refAbstract=null), Reference(id=1325223598469816478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=白立娜, 周健楠. 奥妥珠单抗治疗难治性肾病综合征不良反应的预防与管理实践[J]. 中国现代医药杂志, 2024,26(9): 98-100., articleTitle=null, refAbstract=null), Reference(id=1325223598553702559, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=FURIE RA, ROVIN BH, PENDERGRAFT WF 3rd, et al. Efficacy and safety of obinutuzumab in active lupus nephritis[J]. N Engl J Med, 2025, 393(4): 410., articleTitle=null, refAbstract=null), Reference(id=1325223598645977248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ANGELETTI A, BRUSCHI M, KAJANA X, et al. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment[J]. Front Immunol, 2023, 14: 1213203., articleTitle=null, refAbstract=null), Reference(id=1325223598805360801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=TRILLINI M, PORTALUPI V, GENNARINI A, et al. Prospective cohort study of obinutuzumab in rituximab-resistant primary membranous nephropathy[J]. Kidney Int Rep, 2026, 11(3): 103728., articleTitle=null, refAbstract=null), Reference(id=1325223598914412706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=KOVALIK ME, DACANAY MA, CROWLEY SD, et al. Swollen feet: considering the paradoxical roles of interleukins in nephrotic syndrome[J]. Biomedicines, 2024, 12(4): 738., articleTitle=null, refAbstract=null), Reference(id=1325223600596328611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=REN H, LIN L, SHEN P, et al. Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis[J]. Oncotarget, 2017, 8(55): 93438-93443., articleTitle=null, refAbstract=null), Reference(id=1325223600701186212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG L, ZHU J, XIA M, et al. Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life[J]. Arch Med Sci, 2022, 18(1): 275-278., articleTitle=null, refAbstract=null), Reference(id=1325223600810238117, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU Y, CHEN J, ZHANG Y, et al. Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis[J]. Front Immunol, 2024, 15: 1310032., articleTitle=null, refAbstract=null), Reference(id=1325223600931872934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=VIVARELLI M, COLUCCI M, BONANNI A, et al. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab[J]. Pediatr Nephrol, 2017, 32(1): 181-184., articleTitle=null, refAbstract=null), Reference(id=1325223601036730535, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=KAMEI K, ISHIKURA K, SAKO M, et al. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children[J]. Pediatr Nephrol, 2020, 35(1): 17-24., articleTitle=null, refAbstract=null), Reference(id=1325223601145782440, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=KANG C, BLAIR HA. Ofatumumab: a review in relapsing forms of multiple sclerosis[J]. Drugs, 2022, 82(1): 55-62., articleTitle=null, refAbstract=null), Reference(id=1325223601246445737, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=D'AGATI VD, KASKEL FJ, FALK RJ. Focal segmental glomerulosclerosis[J]. N Engl J Med, 2011, 365(25): 2398-2411., articleTitle=null, refAbstract=null), Reference(id=1325223601351303339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSRIVIJIT P, CHEUNGPASITPORN W, THONGPRAYOON C, et al. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis[J]. Bio Med Central Nephrol, 2020, 21(1): 134., articleTitle=null, refAbstract=null), Reference(id=1325223601439383724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=HAUSER SL, BAR-OR A, COHEN JA, et al. Ofatumumab versus teriflunomide in multiple sclerosis[J]. N Engl J Med, 2020, 383(6): 546-557., articleTitle=null, refAbstract=null), Reference(id=1325223601514881197, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=MEUTH SG, WOLFF S, MUCK A, et al. Different treatment outcomes of multiple sclerosis patients receiving ocrelizumab or ofatumumab[J]. Ann Neurol, 2025, 97(3): 583-595., articleTitle=null, refAbstract=null), Reference(id=1325223601581990062, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=张默, 姚丽. 生物制剂在免疫相关性肾脏疾病中的应用进展[J]. 中国实用内科杂志, 2023, 43(3): 193-197., articleTitle=null, refAbstract=null), Reference(id=1325223601682653359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN L, WANG W, WU Y, et al. Consolidation treatment and long-term prognosis of rituximab in minimal change disease and focal segmental glomerular sclerosis[J]. Drug Des Devel Ther, 2021, 15: 1945-1953., articleTitle=null, refAbstract=null), Reference(id=1325223601770733744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ISAKA Y, SAKAGUCHI Y, SHINZAWA M, et al. Rituximab for relapsing nephrotic syndrome in adults: a randomized clinical trial[J]. J Am Med Assoc, 2025, 334(22): 2011-2019., articleTitle=null, refAbstract=null), Reference(id=1325223601879785650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=CUI Z, ZHAO MH. Anti-nephrin autoantibodies: a paradigm shift in podocytopathies[J]. Nat Rev Nephrol, 2024, 20(10):639-640., articleTitle=null, refAbstract=null), Reference(id=1325223601963671731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=EFE O, SAUVAGE G, JEYABALAN A, et al. Persistent B cell depletion after rituximab for autoimmune and glomerular diseases: a case series[J]. Kidney Int Rep, 2025, 10(5):1441-1449., articleTitle=null, refAbstract=null), Reference(id=1325223602051752116, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=BASU B, ANGELETTI A, ISLAM B, et al. New and old anti-CD20 monoclonal antibodies for nephrotic syndrome. Where we are?[J]. Front Immunol, 2022, 13: 805697., articleTitle=null, refAbstract=null), Reference(id=1325223602148221109, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=LIAUKOUSKAYA N, HENGEL FE, MUHLIG A, et al. A new hope for treating podocytopathies-emerging role of anti-nephrin antibody[J]. Clin J Am Soc Nephrol, 2026, doi:10.2215/CJN.0000001008., articleTitle=null, refAbstract=null), Reference(id=1325223602244690102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=党珊, 马文静. 不同剂量利妥昔单抗治疗原发性难治性肾病综合征的效果对比[J]. 医学理论与实践, 2025, 38(9):1509-1511., articleTitle=null, refAbstract=null), Reference(id=1325223602353742007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=陈梦星, 张丽华, 刘志红. 利妥昔单抗在特发性膜性肾病治疗中的应用[J]. 肾脏病与透析肾移植杂志, 2018, 27(3):274-278., articleTitle=null, refAbstract=null), Reference(id=1325223602475376824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=FREEMAN CL, SEHN LH. A tale of two antibodies:obinutuzumab versus rituximab[J]. Br J Haematol, 2018,182(1): 29-45., articleTitle=null, refAbstract=null), Reference(id=1325223602563457209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=BONDZA S, TEN BROEKE T, NESTOR M, et al. Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent[J]. MAbs, 2020, 12(1): 1792673., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325223592744591493, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, awardId=ptkwws202412, language=CN, fundingSource=上海市普陀区科委课题(ptkwws202412), fundOrder=null, country=null), Fund(id=1325223592870420614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, awardId=2025rmky19, language=CN, fundingSource=2025年度上海市普陀区人民医院科研创新“新锐计划”(2025rmky19), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)]), AuthorCompany(id=1325223585362616422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=2., ext=[AuthorCompanyExt(id=1325223585375199335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223585387782248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.06.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.06.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.06.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.06.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1781020800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗CD20单克隆抗体在难治性肾病综合征中的应用进展
吴宏磊 1 , 严丹莹 1 , 汪年松 2, * , 李军辉 1, *
世界临床药物 | 医药专论 2026,47(6): 589-594
收起
收藏切换
世界临床药物 |医药专论 2026 , 47 (6) : 589 -594
抗CD20单克隆抗体在难治性肾病综合征中的应用进展
全屏
[Author(id=1325223585475862634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223587161972844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223585475862634, language=EN, stringName=Honglei WU, firstName=Honglei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589087158381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223585475862634, language=CN, stringName=吴宏磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio={"content":"

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

"}, bioImg=null, bioContent=

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])]), Author(id=1325223589233959023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223589334622321, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589233959023, language=EN, stringName=Danying YAN, firstName=Danying, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589460451442, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589233959023, language=CN, stringName=严丹莹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio={"content":"

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

"}, bioImg=null, bioContent=

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])]), Author(id=1325223589577891956, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223589674360950, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589577891956, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223589762441335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589577891956, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585362616422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=2., ext=[AuthorCompanyExt(id=1325223585375199335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223585387782248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585362616422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])]), Author(id=1325223589858910329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223589963767931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589858910329, language=EN, stringName=Junhui LI, firstName=Junhui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223591712792700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, authorId=1325223589858910329, language=CN, stringName=李军辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.同济大学附属普陀人民医院肾内科,上海 200060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223585232592995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, xref=1., ext=[AuthorCompanyExt(id=1325223585245175908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China), AuthorCompanyExt(id=1325223585257758821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223584355983456, companyId=1325223585232592995, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.同济大学附属普陀人民医院肾内科,上海 200060)])])]
吴宏磊1, 严丹莹1, 汪年松2, *, 李军辉1, *
作者信息
  • 1.同济大学附属普陀人民医院肾内科,上海 200060
  • 2.上海交通大学医学院附属第六人民医院肾内科,上海 200233
通讯作者:
汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤发病机制和防治
李军辉,副教授,主任医师,研究方向:继发性肾病发病机制和防治。
作者简介:

吴宏磊,硕士,住院医师,研究方向:慢性肾脏病防治

严丹莹,硕士,住院医师,研究方向:慢性肾脏病发病机制研究。

Progress in the application of anti-CD20 monoclonal antibodies in refractory nephrotic syndrome
Honglei WU1, Danying YAN1, Niansong WANG2, *, Junhui LI1, *
Affiliations
  • 1.Department of Nephrology, Putuo People's Hospital Affiliated to Tongji University, Shanghai 200060, China
  • 2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
出版时间: 2026-06-10 doi: 10.13683/j.wph.2026.06.001
文章导航
收藏切换

难治性肾病综合征(refractory nephrotic syndrome,RNS)是原发性肾病综合征中治疗难度较高的亚型,主要包括激素抵抗型和激素依赖/频复发型肾病综合征。传统免疫抑制剂疗效局限且安全性不足,难以满足目前临床需求。抗CD20单克隆抗体凭借靶向性,在RNS治疗中表现优异。现围绕以利妥昔单抗、奥法妥木单抗、奥妥珠单抗为代表的抗CD20单克隆抗体药物展开综述,分析相关作用机制,以及在RNS常见病理类型中的临床疗效与作用差异,为临床提供参考。

抗CD20单克隆抗体  /  难治性肾病综合征  /  免疫治疗  /  B细胞耗竭

Refractory nephrotic syndrome(RNS) is a subtype of primary NS with high treatment difficulty, mainly including steroid-resistant NS and steroid-dependent/frequently relapsing NS. Traditional immunosuppressants have limited efficacy and insufficient safety, which can hardly meet current clinical demands. Anti-CD20 monoclonal antibody(anti-CD20McAb) has shown outstanding performance in the treatment of RNS due to its targeting specificity. This review focuses on anti-CD20McAb drugs, including rituximab, ofatumumab, and obinutuzumab, analyzes their related mechanisms of action, as well as the clinical efficacy and differences among common pathological types of RNS, to provide a reference for clinical practice.

anti-CD20 monoclonal antibody  /  refractory nephrotic syndrome  /  immunotherapy  /  B cell depletion
吴宏磊, 严丹莹, 汪年松, 李军辉. 抗CD20单克隆抗体在难治性肾病综合征中的应用进展. 世界临床药物, 2026 , 47 (6) : 589 -594 . DOI: 10.13683/j.wph.2026.06.001
Honglei WU, Danying YAN, Niansong WANG, Junhui LI. Progress in the application of anti-CD20 monoclonal antibodies in refractory nephrotic syndrome[J]. World Clinical Drug, 2026 , 47 (6) : 589 -594 . DOI: 10.13683/j.wph.2026.06.001
  • 上海市普陀区科委课题(ptkwws202412)
  • 2025年度上海市普陀区人民医院科研创新“新锐计划”(2025rmky19)
参考文献 引证文献
排序方式:
[1]
FLOEGE J, GIBSON KL, VIVARELLI M, et al. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J]. Kidney Int, 2025,107(5S): S241-S289.
[2]
FLOEGE J, GIBSON KL, VIVARELLI M, et al. Executive summary of the KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J]. Kidney Int, 2025, 107(5): 806-808.
[3]
ROVIN BH, ADLER SG, BARRATT J, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases[J]. Kidney Int, 2021, 100(4): S1-S276.
[4]
FERVENZA FC, APPEL GB, BARBOUR SJ, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy[J]. N Engl J Med, 2019, 381(1): 36-46.
[5]
张浩, 蒲正川, 刘丹, 等. 利妥昔单抗联合钙调磷酸酶抑制剂治疗难治性肾病综合征的远期疗效与安全性[J]. 现代生物医学进展, 2025, 25(12): 1948-1954.
[6]
TRAUTMANN A, BOYER O, HODSON E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome[J]. Pediatr Nephrol, 2023, 38(3): 877-919.
[7]
黄瑶, 施克雯, 朱雪婧, 等. 中国单中心 9 310 例肾活检病理诊断疾病谱[J]. 中南大学学报(医学版), 2022, 47(5): 546-554.
[8]
陈勇, 王亚倩, 宁小元, 等. 低剂量利妥昔单抗与环磷酰胺分别联合泼尼松治疗难治性肾病综合征患者的临床评价[J]. 中国药物应用与监测, 2025, 22(5): 938-941.
[9]
刘纹, 许勇芝. 难治性特发性膜性肾病诊治进展[J]. 海南医学, 2021, 32(4): 511-515.
[10]
周雅洁, 吴娅妃. 利妥昔单抗联合环孢素 A 治疗难治性肾病综合征对血清炎症因子肾功能的影响[J]. 中国药物与临床, 2023, 23(5): 297-301.
[11]
KUIJPERS TW, BENDE RJ, BAARS PA, et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses[J]. J Clin Invest, 2010, 120(1): 214-222.
[12]
PAVLASOVA G, MRAZ M. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy[J]. Haematologica, 2020, 105(6): 1494-1506.
[13]
BOROSS P, LEUSEN JH. Mechanisms of action of CD20 antibodies[J]. Am J Cancer Res, 2012, 2(6): 676-690.
[14]
SMITH MR. Rituximab(monoclonal anti-CD20 antibody):mechanisms of action and resistance[J]. Oncogene, 2003,22(47): 7359-7368.
[15]
BECK LH, BONEGIO RG, LAMBEAU G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1):11-21.
[16]
TOMAS NM, BECK LH, MEYER-SCHWESINGER C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24):2277-2287.
[17]
DOTSCH J, MULLER-WIEFEL DE, KEMPER MJ. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?[J]. Pediatr Nephrol, 2008, 23(1): 3-7.
[18]
金众鑫, 乔玉峰. 利妥昔单抗在难治性肾病综合征中的应用现状[J]. 中华肾病研究电子杂志, 2018, 7(5): 234-237.
[19]
于晓艳, 孙珊珊, 李双宇, 等. 对比利妥昔单抗、环磷酰胺及他克莫司治疗肾病综合征的临床研究[J]. 中外医疗, 2023, 42(15): 134-137.
[20]
徐丽梨, 胡晓帆, 李灏, 等. 利妥昔单抗治疗 PLA2R 阴性的原发性膜性肾病患者疗效预测相关指标的研究[J]. 诊断学理论与实践, 2025, 24(3): 279-285.
[21]
TRACHTMAN H, DESMOND H, WILLIAMS AL, et al. Rationale and design of the nephrotic syndrome study network(NEPTUNE) match in glomerular diseases:designing the right trial for the right patient, today[J]. Kidney Int, 2024, 105(2): 218-230.
[22]
向金波, 沈官国, 李政, 等. 抗 CD20 单抗在儿童难治性肾病综合征中的临床应用进展[J]. 中国药房, 2025, 36(16):2078-2084.
[23]
白立娜, 周健楠. 奥妥珠单抗治疗难治性肾病综合征不良反应的预防与管理实践[J]. 中国现代医药杂志, 2024,26(9): 98-100.
[24]
FURIE RA, ROVIN BH, PENDERGRAFT WF 3rd, et al. Efficacy and safety of obinutuzumab in active lupus nephritis[J]. N Engl J Med, 2025, 393(4): 410.
[25]
ANGELETTI A, BRUSCHI M, KAJANA X, et al. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment[J]. Front Immunol, 2023, 14: 1213203.
[26]
TRILLINI M, PORTALUPI V, GENNARINI A, et al. Prospective cohort study of obinutuzumab in rituximab-resistant primary membranous nephropathy[J]. Kidney Int Rep, 2026, 11(3): 103728.
[27]
KOVALIK ME, DACANAY MA, CROWLEY SD, et al. Swollen feet: considering the paradoxical roles of interleukins in nephrotic syndrome[J]. Biomedicines, 2024, 12(4): 738.
[28]
REN H, LIN L, SHEN P, et al. Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis[J]. Oncotarget, 2017, 8(55): 93438-93443.
[29]
WANG L, ZHU J, XIA M, et al. Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life[J]. Arch Med Sci, 2022, 18(1): 275-278.
[30]
ZHU Y, CHEN J, ZHANG Y, et al. Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis[J]. Front Immunol, 2024, 15: 1310032.
[31]
VIVARELLI M, COLUCCI M, BONANNI A, et al. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab[J]. Pediatr Nephrol, 2017, 32(1): 181-184.
[32]
KAMEI K, ISHIKURA K, SAKO M, et al. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children[J]. Pediatr Nephrol, 2020, 35(1): 17-24.
[33]
KANG C, BLAIR HA. Ofatumumab: a review in relapsing forms of multiple sclerosis[J]. Drugs, 2022, 82(1): 55-62.
[34]
D'AGATI VD, KASKEL FJ, FALK RJ. Focal segmental glomerulosclerosis[J]. N Engl J Med, 2011, 365(25): 2398-2411.
[35]
HANSRIVIJIT P, CHEUNGPASITPORN W, THONGPRAYOON C, et al. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis[J]. Bio Med Central Nephrol, 2020, 21(1): 134.
[36]
HAUSER SL, BAR-OR A, COHEN JA, et al. Ofatumumab versus teriflunomide in multiple sclerosis[J]. N Engl J Med, 2020, 383(6): 546-557.
[37]
MEUTH SG, WOLFF S, MUCK A, et al. Different treatment outcomes of multiple sclerosis patients receiving ocrelizumab or ofatumumab[J]. Ann Neurol, 2025, 97(3): 583-595.
[38]
张默, 姚丽. 生物制剂在免疫相关性肾脏疾病中的应用进展[J]. 中国实用内科杂志, 2023, 43(3): 193-197.
[39]
LIN L, WANG W, WU Y, et al. Consolidation treatment and long-term prognosis of rituximab in minimal change disease and focal segmental glomerular sclerosis[J]. Drug Des Devel Ther, 2021, 15: 1945-1953.
[40]
ISAKA Y, SAKAGUCHI Y, SHINZAWA M, et al. Rituximab for relapsing nephrotic syndrome in adults: a randomized clinical trial[J]. J Am Med Assoc, 2025, 334(22): 2011-2019.
[41]
CUI Z, ZHAO MH. Anti-nephrin autoantibodies: a paradigm shift in podocytopathies[J]. Nat Rev Nephrol, 2024, 20(10):639-640.
[42]
EFE O, SAUVAGE G, JEYABALAN A, et al. Persistent B cell depletion after rituximab for autoimmune and glomerular diseases: a case series[J]. Kidney Int Rep, 2025, 10(5):1441-1449.
[43]
BASU B, ANGELETTI A, ISLAM B, et al. New and old anti-CD20 monoclonal antibodies for nephrotic syndrome. Where we are?[J]. Front Immunol, 2022, 13: 805697.
[44]
LIAUKOUSKAYA N, HENGEL FE, MUHLIG A, et al. A new hope for treating podocytopathies-emerging role of anti-nephrin antibody[J]. Clin J Am Soc Nephrol, 2026, doi:10.2215/CJN.0000001008.
[45]
党珊, 马文静. 不同剂量利妥昔单抗治疗原发性难治性肾病综合征的效果对比[J]. 医学理论与实践, 2025, 38(9):1509-1511.
[46]
陈梦星, 张丽华, 刘志红. 利妥昔单抗在特发性膜性肾病治疗中的应用[J]. 肾脏病与透析肾移植杂志, 2018, 27(3):274-278.
[47]
FREEMAN CL, SEHN LH. A tale of two antibodies:obinutuzumab versus rituximab[J]. Br J Haematol, 2018,182(1): 29-45.
[48]
BONDZA S, TEN BROEKE T, NESTOR M, et al. Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent[J]. MAbs, 2020, 12(1): 1792673.
2026年第47卷第6期
65
17
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.06.001
  • 接收时间:2025-12-28
  • 首发时间:2026-11-05
  • 出版时间:2026-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-12-28
  • 修回日期:2026-03-25
基金
上海市普陀区科委课题(ptkwws202412)
2025年度上海市普陀区人民医院科研创新“新锐计划”(2025rmky19)
作者信息
    1.同济大学附属普陀人民医院肾内科,上海 200060
    2.上海交通大学医学院附属第六人民医院肾内科,上海 200233

通讯作者:

汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤发病机制和防治
李军辉,副教授,主任医师,研究方向:继发性肾病发病机制和防治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.06.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏